Has the time finally come to measure hsCRP universally in primary and secondary cardiovascular prevention?

Affiliations

¹ Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
² Deutsches Herzzentrum München, Technische Universität München, DZHK (German Centre for Cardiovascular Research), partner site, Munich Heart Alliance, Munich, Germany.
³ Academic Medical Center of the University of Amsterdam, The Netherlands.
⁴ Cardiology Department, Geneva University Hospital, Geneva, Switzerland.
⁵ Department of Cardiology, University Hospital Zurich, Zurich, Switzerland.

Review

Paul M Ridker et al. Eur Heart J. 2018.

. 2018 Dec 7;39(46):4109-4111.

doi: 10.1093/eurheartj/ehy723.

¹ Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
² Deutsches Herzzentrum München, Technische Universität München, DZHK (German Centre for Cardiovascular Research), partner site, Munich Heart Alliance, Munich, Germany.
³ Academic Medical Center of the University of Amsterdam, The Netherlands.
⁴ Cardiology Department, Geneva University Hospital, Geneva, Switzerland.
⁵ Department of Cardiology, University Hospital Zurich, Zurich, Switzerland.

No abstract available

Comment in

Is the amount of glow predicting the fire? Residual inflammatory risk after percutaneous coronary intervention.
Candreva A, Matter CM. Candreva A, et al. Eur Heart J. 2022 Feb 12;43(7):e10-e13. doi: 10.1093/eurheartj/ehy729. Eur Heart J. 2022. PMID: 30452607 No abstract available.